16-57382259-A-T

Variant summary

Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_002996.6(CX3CL1):​c.421A>T​(p.Thr141Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000412 in 1,456,742 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 0.0000041 ( 0 hom. )

Consequence

CX3CL1
NM_002996.6 missense

Scores

19

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 1.62
Variant links:
Genes affected
CX3CL1 (HGNC:10647): (C-X3-C motif chemokine ligand 1) This gene belongs to the CX3C subgroup of chemokines, characterized by the number of amino acids located between the conserved cysteine residues. This is the only member of the CX3C subgroup, which contains three amino acids between cysteine residues, resulting in a Cys-X-X-X-Cys configuration. The encoded protein contains an extended mucin-like stalk with a chemokine domain on top, and exists in both a membrane-anchored form where it acts as a binding molecule, or, in soluble form, as a chemotactic cytokine. The mature form of this protein can be cleaved at the cell surface, yielding different soluble forms that can interact with the G-protein coupled receptor, C-X3-C motif chemokine receptor 1 gene product. This gene plays a role in a wide range of diseases, including cancer, vasculitis, neuropathies, atherosclerosis, inflammatory diseases, and in human immunodeficiency virus infections. [provided by RefSeq, Sep 2017]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.11497471).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
CX3CL1NM_002996.6 linkuse as main transcriptc.421A>T p.Thr141Ser missense_variant 3/3 ENST00000006053.7 NP_002987.1
CX3CL1NM_001304392.3 linkuse as main transcriptc.166A>T p.Thr56Ser missense_variant 2/2 NP_001291321.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
CX3CL1ENST00000006053.7 linkuse as main transcriptc.421A>T p.Thr141Ser missense_variant 3/31 NM_002996.6 ENSP00000006053 P4
CX3CL1ENST00000565912.1 linkuse as main transcriptc.307A>T p.Thr103Ser missense_variant 2/21 ENSP00000464114
CX3CL1ENST00000563383.1 linkuse as main transcriptc.439A>T p.Thr147Ser missense_variant 3/35 ENSP00000456830 A2
CX3CL1ENST00000564948.1 linkuse as main transcriptc.*132A>T 3_prime_UTR_variant 2/23 ENSP00000457996

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD3 exomes
AF:
0.0000163
AC:
4
AN:
245908
Hom.:
0
AF XY:
0.0000224
AC XY:
3
AN XY:
133922
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.000220
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000412
AC:
6
AN:
1456742
Hom.:
0
Cov.:
31
AF XY:
0.00000691
AC XY:
5
AN XY:
723822
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.000126
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
9.02e-7
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
Cov.:
32
ExAC
AF:
0.0000165
AC:
2

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsApr 26, 2024The c.421A>T (p.T141S) alteration is located in exon 3 (coding exon 3) of the CX3CL1 gene. This alteration results from a A to T substitution at nucleotide position 421, causing the threonine (T) at amino acid position 141 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.099
BayesDel_addAF
Benign
-0.44
T
BayesDel_noAF
Benign
-0.58
CADD
Benign
15
DANN
Benign
0.93
DEOGEN2
Benign
0.41
T;T;.
Eigen
Benign
-0.30
Eigen_PC
Benign
-0.49
FATHMM_MKL
Benign
0.17
N
LIST_S2
Benign
0.46
T;T;T
M_CAP
Benign
0.0046
T
MetaRNN
Benign
0.11
T;T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
1.7
L;.;.
MutationTaster
Benign
1.0
N;N;N;N
PrimateAI
Benign
0.33
T
PROVEAN
Benign
-1.2
N;N;.
REVEL
Benign
0.070
Sift
Benign
0.046
D;D;.
Sift4G
Benign
0.081
T;T;T
Polyphen
1.0
D;.;.
Vest4
0.15
MutPred
0.19
Gain of glycosylation at P142 (P = 0.0807);.;.;
MVP
0.093
MPC
0.49
ClinPred
0.13
T
GERP RS
2.7
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.14
gMVP
0.22

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs781755423; hg19: chr16-57416171; API